Author(s):
Archana Kumari, Priya Sharma, Muskan Sharma
Email(s):
archuarchana2112@gmail.com , bhpriya02@gmail.com , muskansh0072@gmail.com
DOI:
10.52711/0975-4385.2025.00030 
Address:
Archana Kumari, Priya Sharma, Muskan Sharma
Assistant Professor, School of Pharmacy and Emerging Sciences, Baddi University, Baddi, District- Solan, H.P., India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 2,
Year - 2025
ABSTRACT:
The fruit pomegranate, or Punica granatum, has long been utilized for medical purposes for times. Its potential therapeutic properties have drawn more attention in recent years, especially in the treatment of diabetes mellitus. With an emphasis on their possible application in the treatment of diabetes, this article attempts to present an overview of the biological activities of the active ingredients found in pomegranates. Numerous bioactive substances can be found in pomegranates, such as flavonoids, alkaloids, vitamins, minerals, and phenolic compounds (including ellagic acid, punicalagins, and anthocyanins). These substances show a range of biological actions, such as anti-inflammatory, anti-hyperglycemic, anti-hyperlipidemic, anti-inflammatory, and anti-diabetic effects. Pomegranate components' antioxidant qualities are vital in the fight against oxidative stress, which is a major contributing factor to the etiology of diabetes and its sequelae. By eliminating free radicals, preventing lipid peroxidation, and boosting the function of natural antioxidant enzymes, these substances shield pancreatic ß-cells from harm and maintain insulin output and sensitivity. Additionally, by modifying inflammatory signaling pathways and lowering the generation of pro-inflammatory cytokines, pomegranate bioactive components have anti-inflammatory properties. This anti-inflammatory action improves glycaemic management and lowers the risk of diabetic complications by lowering insulin resistance and ß-cell dysfunction.
Cite this article:
Archana Kumari, Priya Sharma, Muskan Sharma. An Overview of Active Constituents of Pomegranates (Punica granatum) as Potential Career in The Management of Diabetes through Biological Activities. Research Journal of Pharmacognosy and Phytochemistry. 2025; 17(2):185-9. doi: 10.52711/0975-4385.2025.00030
Cite(Electronic):
Archana Kumari, Priya Sharma, Muskan Sharma. An Overview of Active Constituents of Pomegranates (Punica granatum) as Potential Career in The Management of Diabetes through Biological Activities. Research Journal of Pharmacognosy and Phytochemistry. 2025; 17(2):185-9. doi: 10.52711/0975-4385.2025.00030 Available on: https://rjpponline.org/AbstractView.aspx?PID=2025-17-2-17
8. REFERENCES:
1. Facciola S. Cornucopia: a Source Book of Edible Plants. Vista, California: Kampong Publications; 1990. p. 166.
2. Kim YH, Choi EM. Stimulation of osteoblastic differentiation and inhibition of interleukin-6 and nitric oxide in MC3T3-E1 cells by pomegranate ethanol extract. Phytother. Res. 2009; 23:737–739.
3. Fahmy HA, Farag MA. Ongoing and potential novel trends of pomegranate fruit peel; a comprehensive review of its health benefits and future perspectives as nutraceutical. Journal of Food Biochemistry. 2022 Jan;46(1): e14024.
4. 4.F. Boussaa, F. Zaouay, F. Burlo-Carbonell, L. Noguera-Artiaga, A. Carbonell-Barrachina, P. Melgarejo, F. Hernandez, M. Mars
5. Mannino G, Chinigò G, Serio G, Genova T, Gentile C, Munaron L, Bertea CM. Proanthocyanidins and where to find them: A meta-analytic approach to investigate their chemistry, biosynthesis, distribution, and effect on human health. Antioxidants. 2021 Jul 30;10(8):1229.
6. Banihani S, Swedan S, Alguraan Z. Pomegranate and type 2 diabetes. Nutrition research. 2013 May 1;33(5):341-8.
7. O'Grady L. Effects of postharvest handling on nutritional quality of pomegranate (Punica granatum) Arils (Doctoral dissertation, Stellenbosch: Stellenbosch University).
8. Hotel B, Petra-Jordan R. The 3 rd International Symposium on Medicinal Plants, Their Cultivation and Aspects of Uses.
9. Melgarejo-Sánchez P, Núñez-Gómez D, Martínez-Nicolás JJ, Hernández F, Legua P, Melgarejo P. Pomegranate variety and pomegranate plant part, relevance from bioactive point of view: A review. Bioresources and Bioprocessing. 2021 Dec; 8:1-29.
10. Vidal A, Fallarero A, Pena BR, Medina ME, Gra B, Rivera F, Gutierrez Y, Vuorela PM. 2003. Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit extracts. J Ethnopharmacol 89:295–300.
11. Larrosa M, Gonzalez-Sarr ´ ´ıas A, Ya´nez-Gasc ˜ on MJ, Selma MV, ´ Azor´ın-Ortuno M, Toti S, Tom ˜ as-Barber ´ an F, Dolara P, Espina JC. 2010. ´ Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A. J Nut Biochem 21(8):717–25.
12. Mart´ınez JJ, Melgarejo P, Hernandez F, Salazar DM, Mart’ R. 2006. Seed characterisation of five new pomegranate (Punica granatum L.) varieties. Sci Hortic 110:241–6.
13. Prakash CV, Prakash I. Bioactive chemical constituents from pomegranate (Punica granatum) juice, seed and peel-a review. International Journal of Research in Chemistry and Environment. 2011 Jul;1(1):1-8.
14. Melgarejo P, Salazar DM, Artes F. Organic acids and sugars composition of harvested pomegranate fruits. European Food Research and Technology. 2000 Aug; 211:185-90.
15. Koleckar V, Kubikova K, Rehakova Z, Kuca K, Jun D, Jahodar L, Opletal L. Condensed and hydrolysable tannins as antioxidants influencing the health. Mini reviews in medicinal chemistry. 2008 May 1;8(5):436-47.
16. Kýralan M, Gölükcü M, Tokgöz H. Oil and conjugated linolenic acid contents of seeds from important pomegranate cultivars (Punica granatum L.) grown in Turkey. Journal of the American Oil Chemists' Society. 2009 Oct;86(10):985-90.
17. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. Journal of ethnopharmacology. 2007 Jan 19;109(2):177-206.
18. Pande G, Akoh CC. Pomegranate cultivars (Punica granatum L.). InNutritional composition of fruit cultivars 2016 Jan 1 (pp. 667-689). Academic Press.
19. Elfalleh W, Tlili N, Ying M, Sheng-Hua H, Ferchichi A, Nasri N. Organoleptic quality, minerals, proteins and amino acids from two Tunisian commercial pomegranate fruits. International Journal of Food Engineering. 2011 Aug 5;7(4).
20. Evtyugin DD, Magina S, Evtuguin DV. Recent advances in the production and applications of ellagic acid and its derivatives. A review. Molecules. 2020 Jun 13;25(12):2745.
21. Singh B, Singh JP, Kaur A, Singh N. Phenolic compounds as beneficial phytochemicals in pomegranate (Punica granatum L.) peel: A review. Food chemistry. 2018 Sep 30; 261:75-86.
22. Borochov-Neori H, Judeinstein S, Harari M, Bar-Ya’akov I, Patil BS, Lurie S, Holland D. Climate effects on anthocyanin accumulation and composition in the pomegranate (Punica granatum L.) fruit arils. Journal of Agricultural and Food Chemistry. 2011 May 25;59(10):5325-34.
23. Sultana B, Anwar F. Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants. Food chemistry. 2008 Jun 1;108(3):879-84.
24. Ding W, Wang H, Zhou Q, Wu C, Gao X, Cheng X, Tian L, Wang C. Simultaneous determination of polyphenols and triterpenes in pomegranate peel based on HPLC fingerprint by solvent extraction and ratio blending method in tandem with wavelength switching. Biomedical Chromatography. 2019 Dec;33(12):e4690.
25. Poyrazoğlu E, Gökmen V, Artιk N. Organic acids and phenolic compounds in pomegranates (Punica granatum L.) grown in Turkey. Journal of food composition and analysis. 2002 Oct 1;15(5):567-75.
26. Rahmani AH. Cassia fistula Linn: Potential candidate in the health management. Pharmacognosy research. 2015;7(3):217.
27. Rahmani AH, Albutti AS, Aly SM. Therapeutics role of olive fruits/oil in the prevention of diseases via modulation of anti-oxidant, anti-tumour and genetic activity. International journal of clinical and experimental medicine. 2014; 7(4):799-808.
28. Rahmani AH, Aldebasi YH. Potential role of carica papaya and their active constituents in the prevention and treatment of diseases. Int J Pharm Pharm Sci.2016; 8:11-15.